top of page
Akamis Bio Header Image

Patients

Guiding patients to the research and resources to support their journey.  

Current Clinical Trials

FORTRESS

This study is evaluating clinical complete response (cCR) rates to NG-350A in combination with chemoradiotherapy (CRT) in adult patients with locally advanced rectal cancer (LARC) and at least one risk factor for local or distant recurrence.

Akamis Bio Virus
Akamis Bio 2 Transgene

FORTRESS Study Fact Sheets

Resources

Akamis Bio is partnered with colorectal cancer patient advocacy organizations to provide patients and their families critical resources and support. These groups offer disease education, tools to navigate treatment options and clinical studies, opportunities to connect with supportive communities, and much more. Following are links to several leading groups in the US and UK:

bottom of page